As the group critical illness market fails to make any headway, Peter Madigan asks what can be done to boost sales Click here to download pdf
While most protection products have experienced disappointingly stagnant sales over the last four years critical illness (CI) products have surged ahead. The picture for the sector as a whole is very healthy, but there is concern that group CI remains a peripheral protection option with a very small share of the employee benefits market. Although growth in the group sector has been steady, it has been far from stunning. Figures from the GE Insurance Solutions Group Risk Market Survey 2004, show that 235 new schemes were established in 2003 bringing the total in force to just 1,866. When t...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes